The Mechanism of Galactosamine Toxicity Revisited; A Metabonomic Study
- 20 June 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 6 (7) , 2711-2719
Abstract
1H NMR spectroscopy was used to investigate the metabolic effects of the hepatotoxin galactosamine (galN) and the mechanism by which glycine protects against such toxicity. Rats were acclimatized to a 0 or 5% glycine diet for 6 days and subsequently administered vehicle, galN (500 mg/kg), glycine (5% via the diet), or both galN and glycine. Urine was collected over 12 days prior to administration of galN and for 24 hours thereafter. Serum and liver tissue were sampled on termination, 24 hours post-dosing. The metabolic profiles of biofluids and tissues were determined using high-field 1H NMR spectroscopy. Orthogonal-projection to latent structures discriminant analysis (O-PLS-DA) was applied to model the spectral data and enabled the hepatic, urinary, and serum metabolites that discriminated between control and treated animals to be determined. Histopathological data and clinical chemistry measurements confirmed the protective effect of glycine. The level of N-acetylglucosamine (glcNAc) in the post-dose urine was found to correlate strongly with the degree of galN-induced liver damage, and the urinary level of glcNAc was not significantly elevated in rats treated with both galN and glycine. Treatment with glycine alone was found to significantly increase hepatic levels of uridine, UDP-glucose, and UDP-galactose, and in view of the known effects of galactosamine, this suggests that the protective role of glycine against galN toxicity might be mediated by changes in the uridine nucleotide pool rather than by preventing Kupffer cell activation. Thus, we present a novel hypothesis: that administration of glycine increases the hepatic uridine nucleotide pool which counteracts the galN-induced depletion of these pools and facilitates complete metabolism of galN. These novel data highlight the applicability of NMR-based metabonomics in elucidating multicompartmental metabolic consequences of toxicity and toxic salvage. Keywords: Metabonomics • Galactosamine Toxicity • Glycine Protection • Mechanism • NMR • O-PLS-DAKeywords
This publication has 23 references indexed in Scilit:
- Chemometrics in MetabonomicsJournal of Proteome Research, 2006
- S-Adenosylmethionine but not glutathione protects against galactosamine-induced cytotoxicity in rat hepatocyte culturesToxicology, 2006
- The Consortium for Metabonomic Toxicology (COMET): Aims, Activities and AchievementsPharmacogenomics, 2005
- Metabonomics: a platform for studying drug toxicity and gene functionNature Reviews Drug Discovery, 2002
- Glycine and Uridine Prevent D –Galactosamine Hepatotoxicity in the Rat: Role of Kupffer CellsHepatology, 1999
- 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic dataXenobiotica, 1999
- Identification of an Interferon-γ Receptor α Chain Sequence Required for JAK-1 BindingJournal of Biological Chemistry, 1996
- Inhibition of galactosamine cytotoxicity in an in vivo/in vitro hepatocellular toxicity modelToxicology and Applied Pharmacology, 1987
- Studies on the Mechanism of Galactosamine Hepatitis: Accumulation of Galactosamine‐1‐Phosphate and its Inhibition of UDP‐Glucose PyrophosphorylaseEuropean Journal of Biochemistry, 1969
- Changes in uridine nucleotides during liver perfusion with D‐galactosamineFEBS Letters, 1969